vimarsana.com

Latest Breaking News On - Garys gillheeney - Page 4 : vimarsana.com

Organogenesis President and Chief Executive Officer Gary S Gillheeney, Sr Elected Chair of the Board of Directors

CANTON, Mass., April 27, 2023 Organogenesis Holdings Inc. , a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the. | April 27, 2023

Garys gillheeneyArthurs leibowitzMike piccininoRon obrienGlobenewswire incA risk factors of the company formOrganogenesis holdings incAudit committeeExchange commissionAdvanced wound careSports medicineChief executive officerLead independent directorPrivate securities litigation reform actRisk factorsMedia inquiries

Organogenesis Holdings Inc (NASDAQ:ORGO) Q4 2022 Earnings Call Transcript

Operator: Welcome, ladies and gentlemen to the Fourth Quarter and Fiscal Year 2022 Earnings Conference Call for Organogenesis Holdings Inc.

United statesDave franciscoGary gillheeneyGarys gillheeneyRyan zimmermanOrganogenesis holdings incOrganogenesis holdingsExchange commissionOrganogenesis holdingHealth photoEarnings conference call for organogenesis holdings incCall transcript marchFourth quarterFiscal yearConference callRisk factors

Organogenesis (ORGO) Q4 2022 Earnings Call Transcript

ORGO earnings call for the period ending December 31, 2022.

United statesDave franciscoGary gillheeneyGarys gillheeneyRyan zimmermanExchange commissionOrganogenesis holdings incOrganogenesis holdingsOrganogenesis holdingRisk factorsChief executiveMotley fool stock advisorStock advisor

vimarsana © 2020. All Rights Reserved.